Regression of aneurysmal type 1 neovascularization after brolucizumab injections. Airaldi M, Cozzi M, Staurenghi G. Can J Ophthalmol 2022;57:e163.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Airaldi M, Cozzi M, Staurenghi G. Regression of aneurysmal type 1 neovascularization after brolucizumab injections. Can J Ophthalmol 2022;57:e163.
PMID: 34606766